Natural age-related sleep-wake alterations onset prematurely in the Tg2576 mouse model of Alzheimer’s disease

Sedef Kollarik, Carlos G. Moreira, Inês Dias, Dorita Bimbiryte, Djordje Miladinovic, Joachim M. Buhmann, Christian R. Baumann, Daniela NoaínbioRxiv 2021 · DOI

TL;DR

This study reveals that sleep disturbances, characteristic of Alzheimer's disease (AD), emerge prematurely in the Tg2576 mouse model, even before the formation of amyloid plaques. This suggests that sleep quality decline is an early, potentially causal factor in AD pathogenesis, offering new avenues for early intervention.

What Problem Does This Paper Address?

Alzheimer's disease (AD) is strongly linked to sleep disturbances, but it's unclear whether these sleep issues are a cause or a consequence of the disease. To investigate this, researchers need reliable animal models that mimic early AD stages. While the Tg2576 mouse is a common model for AD due to its amyloid precursor protein (APP) mutation, its sleep-wake patterns, especially in the preclinical stages, haven't been thoroughly characterized. This gap hinders the development and testing of sleep-based therapeutic interventions for AD before significant neurodegeneration occurs. This paper aims to fill this gap by examining the age-dependent sleep-wake phenotype of Tg2576 mice at both plaque-free (pre-morbid) and plaque-burdened stages.

Methods

The researchers used electroencephalography (EEG) and electromyography (EMG) to record the sleep-wake patterns of Tg2576 mice and age-matched wild-type (WT) controls. These recordings were conducted over 24-hour periods in mice at two key ages: 6 months old (pre-morbid, plaque-free) and 11 months old (moderate plaque burden).

Key techniques included:

  • EEG/EMG Implantation: Surgical implantation of headpieces to record brain activity (EEG) and muscle tone (EMG).
  • Polysomnography: Continuous 24-hour recording of EEG and EMG signals.
  • Sleep Scoring: Automated analysis of EEG/EMG data using the SPINDLE software to classify sleep into three vigilance stages: Wakefulness (WAKE), Non-Rapid Eye Movement (NREM) sleep, and Rapid Eye Movement (REM) sleep.
  • Spectral Analysis: Examination of EEG power in different frequency bands (delta, theta, alpha, sigma, beta) during each vigilance state to assess brain activity patterns.
  • Congo Red Staining: A histological technique used to visualize and quantify amyloid plaques in brain tissue, specifically in the hippocampus.
  • Stereology: A method for estimating the volume and density of plaques within the hippocampus.
  • Statistical Analysis: Two-way ANCOVA and mixed ANOVA were used to analyze the effects of genotype, age, and their interactions on various sleep parameters and EEG spectral power.

Datasets

Not discussed in the paper. The study utilized data collected from their own experimental setup involving Tg2576 and WT mice.

Key Insights and Ideas

  • Premature Sleep Deterioration: The most striking finding is that Tg2576 mice exhibit sleep disturbances (increased wakefulness, decreased NREM sleep, reduced slow-wave energy) at a young, plaque-free stage, mirroring patterns seen in aged, healthy individuals. This suggests that sleep problems are not merely a symptom of advanced AD but an early, potentially contributing factor.
  • Aging Masks Genotype Differences: While younger Tg2576 mice show clear sleep alterations compared to WT controls, these differences become less pronounced in older (11-month-old) mice. The authors propose this is because WT mice also experience age-related sleep changes, effectively masking the genotype-specific effects.
  • Sleep Quality as a Biomarker: The early onset of sleep-wake alterations, particularly the reduced slow-wave energy, could serve as a valuable preclinical biomarker for AD, allowing for earlier detection and intervention.
  • Bidirectional Relationship: The findings reinforce the idea of a bidirectional relationship between sleep and AD, where disrupted sleep may exacerbate amyloid pathology, and amyloid accumulation may further disrupt sleep.

Key Results

  • Increased Wakefulness and Decreased NREM Sleep: At 6 months old, Tg2576 mice showed significantly higher wakefulness and lower NREM sleep during the dark (active) period compared to WT controls. This pattern persisted, though less pronounced, at 11 months.
  • Reduced Slow-Wave Energy (SWE): 6-month-old Tg2576 mice exhibited significantly lower cumulative SWE, indicating impaired sleep depth and quality, even before plaque formation. This difference was not observed in 11-month-old mice.
  • EEG Spectral Power: While genotype had a significant effect on beta band power during wakefulness in older mice, age was a more consistent factor influencing delta and sigma band power in NREM sleep, and delta, theta, alpha, and sigma power in REM sleep across both genotypes.
  • Plaque Burden: Amyloid plaques were confirmed in the hippocampus of 11-month-old Tg2576 mice, but not in the 6-month-old Tg2576 mice, aligning with the observed sleep changes preceding plaque accumulation.

Limitations and Future Work

  • REM Sleep Staging Accuracy: The authors acknowledge that REM sleep staging accuracy is dependent on EMG signal quality, which introduced variability in their analysis.
  • Chronobiological Assessment: The study lacked purely chronobiological assessments (e.g., circadian rhythms), making it difficult to rule out circadian misalignments as a contributing factor to the observed sleep-wake patterns.
  • Limited Age Range: The study focused on two early stages of AD progression. Future work could explore later stages to understand the full trajectory of sleep changes.
  • Worsening Disease Progression: The authors suggest further research is needed to determine if these sleep disturbances in Tg2576 mice can, in turn, worsen disease progression.
  • Protein Handling and Accumulation: The early-onset altered delta activity's impact on protein handling and accumulation in AD warrants further investigation.
  • Biomarker Potential: The potential of specific sleep-wake alterations as clinical biomarkers for pre-morbid AD in humans needs to be explored.

Summary updated

Abstract

Abstract Sleep insufficiency or decreased quality have been associated with Alzheimer’s disease (AD) already in its preclinical stages. Whether such traits are also present in rodent models of the disease has been poorly addressed, somewhat disabling the preclinical exploration of sleep-based therapeutic interventions for AD. We investigated age-dependent sleep-wake phenotype of a widely used mouse model of AD, the Tg2576 line. We implanted electroencephalography/ electromyography headpieces into 6 months old (plaque-free, n=10) and 11 months old (moderate plaque-burdened, n=10) Tg2576 and age-matched wild-type (WT) mice and recorded vigilance states for 24 hours. Tg2576 mice exhibited significantly increased wakefulness and decreased non-rapid eye movement sleep over a 24-hour period compared to WT mice at 6, but not at 11 months of age. Concomitantly, delta power appeared decreased in 6-month old Tg2576 mice in comparison to age-matched WT controls, yielding a reduced slow-wave energy phenotype in the young mutants. Lack of genotype-related differences over 24 hours in overall sleep-wake phenotype at 11 months of age appears to be the result of the natural aging of WT mice. Therefore, our results indicate that at plaque-free stages of the disease, diminished sleep quality is present in Tg2576 mice which resembles aged healthy controls, suggesting an early-onset of sleep-wake deterioration in murine AD. Whether such disturbances in the natural patterns of sleep could in turn worsen disease progression warrants further exploration.
BibTeX
@misc{kollarik2021natural,
  author = {Sedef Kollarik and Carlos G. Moreira and Inês Dias and Dorita Bimbiryte and Djordje Miladinovic and Joachim M. Buhmann and Christian R. Baumann and Daniela Noaín},
  title = {{Natural age-related sleep-wake alterations onset prematurely in the Tg2576 mouse model of Alzheimer’s disease}},
  year = {2021},
  doi = {10.1101/2021.10.25.465747},
  howpublished = {bioRxiv},
}
Figure